"To us, physician
engagement is a key to success — in collaboration with our customers, Magellan
Rx pharmacists performed extensive outreach and education on the biosimilar
products to prescribing physicians."
— Steve Cutts,
senior vice president and general manager of specialty drugs at Magellan Rx
Management, talked with AIS’s RADAR
on Specialty Pharmacy about how the PBM handles provider pushback
against biosimilar usage.
No comments:
Post a Comment